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Clinical Scenario: A common overuse injury in athletics is plantar fasciitis. Plantar fasciitis 
is usually treated conservatively with the use of analgesics and anti-inflammatory 
medications like NSAIDs. When this condition becomes chronic and conservative methods 
have failed; a different intervention may be indicated. Focused Clinical Question: In 
patients with chronic plantar fasciitis, what is the effect on platelet rich plasma injection 
vs. corticosteroid injection on pain? Search Strategy: Pubmed, Proquest Nursing, 
Cochrane Library, and CINAHL Plus databases were searched using terms: Plantar fasciitis, 
platelet rich plasma injection, and corticosteroid injections. Inclusion criteria were 
patients with chronic plantar fasciitis that failed conservative treatment, platelet rich 
plasma injection, corticosteroid injection, and articles published after the year 2002. 
Exclusion criteria were publications dates prior to the year 2002 and chronic injuries other 
than plantar fasciitis. Initial search revealed 273 articles which were narrowed to eight 
articles after reviewing the inclusion and exclusion criteria. Evidence Quality Assessment: 
Eight articles were collected; all eight articles scored a two or three on the Oxford levels 
of incidence chart. PEDro scale scores ranged from a score of 4/10 to 6/10. Results and 
Summary of Search: Four out of eight articles concluded that platelet rich plasma is 
equally as effective as corticosteroid injection on reducing pain in patients. In the other 
four articles, platelet rich plasma was shown to be more effective than corticosteroid 
injection on reducing pain. Platelet rich plasma has a longer lasting effect than 
corticosteroid injection, but corticosteroid injection is less invasive and safer than platelet 
rich plasma injection. Platelet rich plasma proved to last up to twelve months in 
effectiveness where corticosteroid lasted up to six months post injection. Pain in all 
articles was measured using the visual analog scale (VAS). Strengths of the articles PEDro
criteria were concealed randomly allocated groups that were similar at baseline testing 
and results reported for at least one key outcome had variability and were obtained from 
at least 85% patients that were in the article. Weaknesses included blinding of patients 
and assessors. Clinical Bottom Line: The conclusions based on the evaluated research is 
that platelet rich plasma is equally as, if not more, effective as corticosteroid injection on 
reducing pain in patients with chronic plantar fasciitis. Platelet rich plasma has a longer 
lasting effect than corticosteroid injection, but corticosteroid injection is less invasive and 
safer than platelet rich plasma injection. Both treatments showed improvement in 
patients with chronic plantar fasciitis and are effective based on the patient’s symptoms 
and goals from treatment. However, platelet rich plasma may prove to be superior due to 
longer lasting effects of the treatment. The SORT score is an A level of recommendation. 
Implications: This information can be used to educate patients on possible treatments 
that they can choose from if conservative treatment of plantar fasciitis fails. Depending 
on state law and what the supervising physician allows, an athletic trainer may be able to 
perform this procedure and should know which treatment could be most effective for 
patients.
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PURPOSE
• In patients with chronic plantar fasciitis, what is the effect on platelet rich 
plasma injection vs. corticosteroid injection on pain?
• Pubmed, Proquest Nursing, Cochrane Library, and CINAHL Plus were searched using 
the terms: Plantar fasciitis, platelet rich plasma injection, and corticosteroid 
injections.
• Inclusion criteria were patients with chronic plantar fasciitis that failed conservative 
treatment, platelet rich plasma injection, corticosteroid injection, and articles 
published after the year 2002. 
• Exclusion criteria were publication dates prior to the year 2002 and chronic injuries 
other than plantar fasciitis. Initial search revealed 273 articles. 
• Articles were narrowed to eight articles after reviewing inclusion and exclusion 
criteria. 
Plantar fasciitis is a common overuse injury. It can be caused by a variety of 
mechanisms but is a repetitive use trauma to the plantar fascia. This stress can be 
intensified leading to plantar fasciitis with improper footwear, change in running 
surfaces, change in shoes, or repetitive use without rest including activities that 
stretch the plantar fascia like running, jumping, etc. This research is aimed to 
answer the question, in patients with chronic plantar fasciitis what is the effect on 
platelet rich plasma versus corticosteroid injection on pain? Patients must have 
failed conservative treatment to be eligible for participation in any of the articles. 
Pain is being measured based on the visual analog scale which is a rating of 
perceived pain to the patient. The importance of knowing the pain outcome of the 
treatment is how functional the patient can be due to perceived pain. 
• Four articles concluded that platelet rich plasma is equally as effective as 
corticosteroid injection on reducing pain in patients. 
• Four articles concluded platelet rich plasma was shown to be more effective than 
corticosteroid injection on reducing pain in patients with chronic plantar fasciitis. 
• Platelet rich plasma has a longer lasting effect on pain than corticosteroid 
injection in patients with chronic plantar fasciitis
• Corticosteroid injection is less invasive and is safer than platelet rich plasma 
injection for the patient. 
• Platelet rich plasma proved to last up to twelve months in effectiveness on 
decreased pain
• Corticosteroid injection lasted up to six months post injection for effectiveness 
on decreased pain. 
• Perceived pain of the patient in all articles was measured using the visual analog 
scale (VAS). 
• Strengths of the articles were concealed randomly allocated groups that were 
similar at baseline testing and results reported for at least one key outcome, had 
variability in results, and were obtained from at least 85% patients that were 
originally in the article. 
• Weaknesses of the articles collected included blinding of patients and assessors. 
This can be a decision of ethical practice as the treatments being discussed are 
surgical procedures.
• Conclusions based on the evaluated research is platelet rich plasma is equally as, if not 
more, effective as corticosteroid injection on reducing pain in patients with chronic 
plantar fasciitis. 
• Platelet rich plasma was proven to have a longer lasting effect on pain than 
corticosteroid injection
• Corticosteroid injection is less invasive and safer than platelet rich plasma injection for 
the patient. 
• Both treatments showed improvement in reduction of pain for patients and are 
effective based on the patient’s symptoms and goals from treatment. 
• Platelet rich plasma may prove to be superior due to longer lasting effects of the 
treatment on decreasing pain. 
• SORT score is an A level of recommendation.
The information collected from the articles can be used to educate patients on possible 
treatments they may have to choose from if conservative treatment of plantar fasciitis 
fails. The failure of conservative treatment may lead to these more invasive procedures 
especially if pain is a factor in their performance or activity level. Depending on where an 
Athletic Trainer practices, state law and the supervising physician, may allow an athletic 
trainer to be able to perform these procedures and should know which treatment could 
be most effective for their patients based on their goals of treatment.
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• Each individual article was evaluated using the PEDro scale and the Oxford 
levels of evidence quality assessment scale.
• All eight articles scored a two or three on the Oxford levels of incidence scale 
as they were clinical trial studies. 
• Thscale scores for the eight articles ranged from a score of 4/10 to 6/10. e 
PEDro
Author Number of Subjects Outcomes P-Value
Aksahin 60 Platelet Rich Plasma is as Effective as Corticosteroid >0.05
Jain 46 Platelet Rich Plasma is More Effective 0.033
Kalaci 50 Platelet Rich lasma is as Effective as Corticosteroid 0.21
Karimzadeh 36 Platelet Rich Plasma is as Effective as Corticosteroid 0.06
Mahindra 75 Platelet Rich Plasma is More Effective 0.41
Monto 40 Platelet Rich Plasma is More Effective 0.001
SAY 50 Platelet Rich Plasma is More Effective 0.05
Shetty 60 Platelet Rich Plasma is as Effective as Corticosteroid 0.483
